Polaris Inc (PII) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2024, Polaris Inc (PII) reported revenue of $1.74 billion, down 20.3% over the same period last year. EPS came in at $0.23, compared to $2.05 in the year-ago quarter. The reported revenue represents a surprise of -0.
Novartis AG raised its forecast as sales of blockbuster medicines for heart disease and psoriasis outpaced expectations, ...
A double beat on the latest quarterly results and raised guidance made investors happy.
Novartis (NVS) comfortably beats first-quarter earnings and sales estimates. The company ups its outlook for 2024 on strong ...
Novartis AG's shares were gaining more than 4 percent in Switzerland and more than 5 percent in pre-market activity on the NYSE after ...
Novartis has been hit with a lawsuit by people with autism and their mothers alleging the drugmaker illegally promoted an ...
Novartis has started cutting ties with Chinese contractors amid a potential threat from the BIOSECURE Act. | Novartis has ...
Swiss drug major Novartis AG (NVS) reported Tuesday that its first-quarter net income was $2.69 billion, higher than last year's ...
Beat-and-raise first quarter puts Novartis in a good position for shareholder value creation in the following years. Read ...
Shares of Swiss drugmaker Novartis climbed 4.8% in early deals Tuesday after it raised its full-year guidance following ...
BASEL, Switzerland — BASEL, Switzerland — Novartis AG (NVS) on Tuesday reported first-quarter profit of $2.69 billion. The Basel, Switzerland-based company said it had net income of $1.31 per share.
Shares of Swiss pharma giant Novartis AG (NYSE:NVS) after the company raised its full-year guidance following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback